This trial is testing a new drug, nedisertib, to see if it can help shrink tumors when used with radiation therapy in patients with a certain type of brain cancer.
2 Primary · 7 Secondary · Reporting Duration: Up to 3 years
Experimental Treatment
29 Total Participants · 2 Treatment Groups
Primary Treatment: Radiation Therapy · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: